Christopher Moxham

New York Blood Center, Inc. operates blood distribution and research organizations. It provides blood and blood products for transfusions annually. The company was founded in 1964 and is located in New York, NY.

MPM Bioimpact Inc (MPM Capital) is a venture capital firm founded in 1996 by Ansbert K. Gadicke and Luke B. Evnin. The firm is headquartered in Boston, Massachusetts.

Trinity Health Corp. engages in the provision of healthcare services. It offers health volunteers, cancer network, senior services management, integrity and compliance, and population health and supply chain management solutions. The firm operates hospitals, home health agencies, and hospice programs. The company was founded on May 1, 2013 and is headquartered in Livonia, MI.

Inova Health System provides health care services. It operates a network of hospitals, nursing homes, assisted living facilities, outpatient services and facilities, primary and specialty care physician practices, emergency and urgent care centers, home health care, mental health and blood donor services, wellness classes, and more. The company was founded in 1956 and is headquartered in Falls Church, VA.

The Global Good Fund is a non-profit social impact accelerator that invests in people to ignite positive impact and lasting social change. The private company is based in Washington. The organization offers fellowship and other nonprofit programs that strengthen the leadership capacity of innovators who are focused on solving complex issues. The Global Good Fund has supported over 200 entrepreneurs across 40 countries, creating 3,000+ permanent jobs and effecting positive change for more than 10,000,0000 people around the world. The organization also provides customized small business coaching and technical assistance, leadership development programs, and advisory services for other organizations through its consulting practice. The Global Good Fund's sister organization, the Impact Fund, is a venture capital fund that invests in mission-driven companies, with a focus on those led by people of color and women. The American company was founded by Carrie Rich. Carrie Rich has been the CEO since incorporation.

Rezon8 Capital & Advisory Group LLC (Rezon8 Capital & Advisory Group) is a private equity firm founded in 2011 by K. Paul Singh. The firm is headquartered in Reston, Virginia.

CureDuchenne Ventures LLC (CureDuchenne Ventures) is a venture capital subsidiary of CureDuchenne, founded in 2014 by Debra Miller. The firm is headquartered in Newport Beach, California.

Kalocyte, Inc. operates as a pre-clinical stage healthcare biotech company. It provides artificial red blood cell substitutes used for trauma care related services. The company was founded in 2016 and is headquartered in Baltimore, MD.

AllStripes Research, Inc. engages in the provision of drug development services. It offers patients and families to get access to and benefit from their own medical data. The company was founded by Onno Faber and Nancy Yu and is headquartered in San Francisco, CA.

Aronora, Inc. operates as an early clinical stage translational biopharmaceutical company. It researches and develops proprietary biological therapeutics. The company was founded by Andras Gruber and Erik I. Tucker and is headquartered in Portland, OR.

Cabinet Health, Inc. is an American sustainable healthcare company that offers healthcare products and services. The company is based in Washington. Cabinet Health is an online pharmacy that provides medicines for various health issues such as cold, upset stomach, and more. The company was founded by Russell Gong and Achal Patel in 2018 with a vision to revolutionize the way the industry packages and fills every type of medicine. Achal Patel has been the CEO since incorporation.

Catena Biosciences, Inc. is an American biotech company that was founded in May 2021. The company is based in El Cerrito, CA. The company is based on technology developed in the Doudna and Francis labs at the University of California, Berkeley. Catena Biosciences' patented technology, called the Catenase platform, allows the construction of biomolecules that are currently unobtainable using modern manufacturing techniques. The platform has applications across multiple therapeutic areas, with an initial focus in oncology. The company is the recipient of an NIH SBIR grant and the American Cancer Society's BrightEdge Golden Ticket at UC's Bakar Labs. The company was founded in 2020 by Marco Lobba, Gregorio Guillen, Matthew B. Francis. Marco Lobba has been the CEO since 2020.

Thymmune Therapeutics is a preclinical biotechnology company located in the US that is developing a machine learning-enabled thymic cell engineering platform to restore normal immune function in aging and disease. The American company's approach in ipsc-thymic cell manufacturing can generate off-the-shelf cells at scale. Thymmune is developing a pipeline of therapies to treat immunodeficiencies, transplant-related, and autoimmune diseases. The company has strong IP positioning and is backed by early investors and founders of successful high-profile biotechnology companies.

NYBC Ventures (NYBC Ventures) is a venture capital subsidiary of New York Blood Center Inc founded in 2022. The firm is headquartered in Boston, Massachusetts.